ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

10,807Medicare Part D Prescriptions Filled, Including Refills

Rank: 165 out of 1206

$590K Total Retail Price of All Prescriptions

Rank: 95 out of 1206

409 Patients Receiving at Least One Drug in Part D
79%Patients 65 Years and Older
55% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Iowa
Lower avg

Schedule Two
Controlled Substances

10% of this provider’s 409 patients filled at least one prescription for a schedule two drug, compared to an average of 4%.

Schedule Three
Controlled Substances

17% of this provider’s 409 patients filled at least one prescription for a schedule three drug, compared to an average of 10%.

Risky Drugs to Seniors

1% of this provider’s 8,762 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

24% of this provider’s prescriptions were for brand-name drugs, compared to an average of 21%.

Prescription Price

$55 was the average price of a prescription from this provider, compared to $46 among peers.

Prescriptions per Patient

26 is the average number of prescriptions (including refills) per patient, compared to an average of 20.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Iowa
LEVOTHYROXINE SODIUM 459 388 1 2
FUROSEMIDE 421 383 2 5
OMEPRAZOLE 407 362 3 3
SIMVASTATIN 361 325 4 1
LISINOPRIL 304 256 5 4
HYDROCODONE-ACETAMINOPHEN 262 156 S3 6 7
POTASSIUM CHLORIDE 248 220 7 12
WARFARIN SODIUM 237 202 8 8
AMLODIPINE BESYLATE 215 192 9 6
METOPROLOL TARTRATE 182 169 10 9
METFORMIN HCL 164 138 11 10
METOPROLOL SUCCINATE 154 139 12 15
DONEPEZIL HCL 143 131 13 29
PREDNISONE 143 127 13 28
HYDROCHLOROTHIAZIDE 142 113 15 11
GABAPENTIN 138 113 16 18
ATORVASTATIN CALCIUM 137 101 17 13
NEXIUM 128 112 18 47
MELOXICAM 126 113 19 35
CITALOPRAM HBR 123 85 20 16
POLYETHYLENE GLYCOL 3350 114 101 21 31
FOSINOPRIL SODIUM 103 77 22 209
CRESTOR 103 79 22 30
ESCITALOPRAM OXALATE 99 85 24 86
CARBIDOPA-LEVODOPA 93 75 25 70
LEVOFLOXACIN 93 73 25 78
TAMSULOSIN HCL 92 85 27 26
FLUTICASONE PROPIONATE 86 78 28 42
SERTRALINE HCL 81 69 29 22
NAMENDA 78 78 30 36
FENTANYL 77 44 S2 31 51
ATENOLOL 77 53 31 14
ADVAIR DISKUS 75 64 33 55
LANTUS 71 53 34 38
ALBUTEROL SULFATE 69 69 35 123
RISPERIDONE 69 45 35 74
FLUOXETINE HCL 69 56 35 52
QUETIAPINE FUMARATE 68 56 38 79
AMITRIPTYLINE HCL 66 52 R 39 59
TRAMADOL HCL 64 52 40 17
ZOLPIDEM TARTRATE 63 47 41 25
DIOVAN 63 50 41 57
ALLOPURINOL 63 55 41 24
ALENDRONATE SODIUM 62 56 44 19
SULFAMETHOXAZOLE-TRIMETHOPRIM 60 51 45 82
ROPINIROLE HCL 57 50 46 77
CIPROFLOXACIN HCL 54 47 47 61
FENOFIBRATE 53 51 48 56
METFORMIN HCL ER 52 32 49 58
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on April 23, 2012.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.